lifestyle.capitolhilltimes.com

  • Animals
  • Auto
  • Beauty & Style
  • Business News
  • Entertainment
  • Food
  • Health
  • Home & Family
  • Podcasts
  • Tech
  • Travel

Business

Latest Business News

  • Lexaria Announces New R&D Plans for 2026

    Lexaria Announces New R&D Plans for 2026

    Lexaria Bioscience Corp.
    March 4, 2026
  • Elektros Secures U.S. Patent for Multi-Port EV Charging Architecture Designed to Enable Ultra-Fast Electric Vehicle Refueling

    Elektros Secures U.S. Patent for Multi-Port EV Charging Architecture Designed to Enable Ultra-Fast Electric Vehicle Refueling

    Elektros, Inc.
    March 4, 2026
  • Cinematic Apps Launches Line, A New Entertainment Production Platform, Upending the Outdated and Inefficient Systems in Hollywood and Beyond

    Cinematic Apps Launches Line, A New Entertainment Production Platform, Upending the Outdated and Inefficient Systems in Hollywood and Beyond

    Cinematic Apps, Inc.
    March 4, 2026
  • M.D. Sass Brings High Conviction Value Strategy to ETF Market

    M.D. Sass Brings High Conviction Value Strategy to ETF Market

    M.D. Sass / DLPR
    March 4, 2026
  • Andor Health Sweeps Industry Honors

    Andor Health Sweeps Industry Honors

    Andor Health
    March 4, 2026
  • FreightWise Appoints Chris Haarmeyer as Chief Technology Officer to Drive Innovation and AI Advancement

    FreightWise Appoints Chris Haarmeyer as Chief Technology Officer to Drive Innovation and AI Advancement

    FreightWise
    March 4, 2026
  • PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO SELL SPATIAL BUSINESS SYSTEMS TO ENVERUS, A BLACKSTONE COMPANY

    PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO SELL SPATIAL BUSINESS SYSTEMS TO ENVERUS, A BLACKSTONE COMPANY

    Kekst and Company Incorporated
    March 4, 2026
  • Octane Surpasses $2 Billion in Originations in Record Year

    Octane Surpasses $2 Billion in Originations in Record Year

    Octane Lending, Inc
    March 4, 2026
  • Citius Oncology Announces Preliminary Topline Phase 1 Data from Study of LYMPHIR™ (E7777) Dosing Prior to Commercial CAR‑T Therapy in High‑Risk Diffuse Large B‑Cell Lymphoma

    Citius Oncology Announces Preliminary Topline Phase 1 Data from Study of LYMPHIR™ (E7777) Dosing Prior to Commercial CAR‑T Therapy in High‑Risk Diffuse Large B‑Cell Lymphoma

    Citius Oncology, Inc.
    March 4, 2026
  • Newport Healthcare Announces Promotion of Kristin Wilson, MA, LPC, CCTP-II, to Chief Growth & Experience Officer

    Newport Healthcare Announces Promotion of Kristin Wilson, MA, LPC, CCTP-II, to Chief Growth & Experience Officer

    5W PUBLIC RELATIONS
    March 4, 2026
Prev
1 … 5,627 5,628 5,629 5,630 5,631 … 30,894
Next

Channels

Follow Us

  • X
  • LinkedIn

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.